Pharma Mar SA (PHM) Stock Statistics & Valuation Metrics

Pharma Mar SA has a market cap or net worth of $1.37B. The enterprise value is €1.30B.

Pharma Mar SA has 18,222,227 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharma Mar SA’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Pharma Mar SA is ―. Pharma Mar SA’s PEG ratio is ―.

In the last 12 months, Pharma Mar SA had revenue of 158.15M and earned 1.14M in profits. Earnings per share was 0.06.

In the last 12 months, operating cash flow was 1.65M and capital expenditures -19.32M, giving a free cash flow of -17.67M billion.

Pharma Mar SA pays an annual dividend of €0.526, resulting in a dividend yield of 0.81%

Pharma Mar SA upcoming earnings date is Apr 24, 2025, TBA Not Confirmed.

Pharma Mar SA as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Pharma Mar SA has paid -4.76M in taxes.

Pharma Mar SA EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Pharma Mar SA has $144.39M in cash and marketable securities with €42.63M in debt, giving a net cash position of -$105.92M billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Pharma Mar SA is $108.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy